Supernus Pharmaceuticals
SUPN
#4553
Rank
A$3.55 B
Marketcap
A$61.05
Share price
0.00%
Change (1 day)
-10.31%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: A$3.55 Billion

As of August 2026 Supernus Pharmaceuticals has a market cap of A$3.55 Billion. This makes Supernus Pharmaceuticals the world's 4553th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.55 B-19.56%
2025A$4.41 B33.75%
2024A$3.30 B42.23%
2023A$2.32 B-18.1%
2022A$2.83 B32.47%
2021A$2.13 B23.65%
2020A$1.72 B-2.8%
2019A$1.77 B-27.86%
2018A$2.46 B-5.72%
2017A$2.61 B50.79%
2016A$1.73 B91.94%
2015A$0.90 B107.44%
2014A$0.43 B28.95%
2013A$0.33 B59.97%
2012A$0.21 B

End of Day market cap according to different sources

On Aug 30th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

A$3.54 Billion
by Nasdaq info icon info icon
A$3.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$895.93 B 25,128.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$266.00 B 7,390.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.442 T 40,527.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$189.86 B 5,246.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
A$2.09 B-41.02%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$30.58 B 761.12%๐Ÿ‡บ๐Ÿ‡ธ USA